What Are the Signs and Symptoms of Lung Cancer?

This content has been reviewed and approved by

Chandra P. Belani, MD
Deputy Director, Penn State Cancer Institute
Miriam Beckner Professor of Medicine
Penn State University School of Medicine
 


In the early stages of lung cancer, you may not experience any obvious signs or symptoms. That’s why most lung cancers are diagnosed when the cancer is relatively advanced.

Early warning signs include a progressively worsening cough. This cough occurs when cancer cells irritate the lining of the airways or block the flow of air.

The following are the most common warning signs and symptoms of lung cancer. However, everyone may experience symptoms differently.

  • Persistent cough
  • Chest pain
  • Shortness of breath
  • Wheezing
  • Recurring lung infections, such as pneumonia or bronchitis
  • Bloody or rust-colored sputum (spit)
  • Hoarse voice
  • Swelling of the neck and face (caused by a tumor that presses on large blood vessels near the lung)
  • Pain and weakness in the shoulder, arm, or hand (caused by a tumor that presses on certain nerves near the lung)
  • Fever for unknown reason

Like other cancers, lung cancer can cause:

  • Fatigue
  • Loss of appetite
  • Weight loss
  • Pain in other parts of the body not affected by the cancer
  • Bone fractures

Lung cancer can cause other symptoms. Some lung cancer cells produce a substance that causes a sharp drop in the level of sodium (salt) in the blood. This can cause many symptoms, including confusion and sometimes even coma.

None of these symptoms is a sure sign of lung cancer, and all are common in other health conditions. Always consult your doctor for a diagnosis.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Non-Small Cell Lung Cancer News
FDA proposes targeted drug testing guidelines

July 12, 2011 — WASHINGTON (Reuters) - Targeted drugs or therapies up for U.S. regulatory approval would have to be reviewed simultaneously with the diagnostic devices they rely on, according to a proposed policy issued on Tuesday.

Roche's Tarceva helps lung cancer patients

June 3, 2011 — ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease getting worse, a late-stage trial showed on Friday.

Counting lung cancer cells helps predict disease

March 21, 2011 — LONDON (Reuters) - British scientists have found that counting the number of lung cancer cells circulating in a patient's blood could help determine how aggressive the cancer is and predict the best treatment to use.

Select news items provided by Reuters Health